Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
The Impact of Faith-Based Organisations on Public Health and Social Capital

As a network of faith-based organisations, FaithAction knows that there are many faith groups up and down the country doing health-related work in their communities. However, the value of this work is in danger of not being recognised, both by the groups themselves and by policymakers, in large part because there is a lack of evidence around what is taking place and its effectiveness.

Published
18 hours ago
From
Faith Action
Treatment Action Campaign faces closure

After almost two decades spent fighting for HIV treatment and access to medicines, the Treatment Action Campaign (TAC) may close its doors due to a severe funding shortage.

Published
18 hours ago
From
Health-e
Europe: Pharma industry denies it lobbied for medicines to move to DG Enterprise

Europe’s pharmaceutical industry has said it did not lobby for medicines and medical devices to be moved from the European Commission's health directorate (DG Sanco) to the enterprise directorate (DG Enterprise).

Published
18 hours ago
From
EurActiv
Exclusive: India set to run out of critical free drug for HIV/AIDS program

India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month.

Published
18 hours ago
From
Reuters
J&J makes a splash in hep C with a $1.75B deal for Alios

Johnson & Johnson ($JNJ) is taking a deep dive into antivirals, trading $1.75 billion for private biotech Alios BioPharma to get its hands on a midstage treatment and some early assets that could expand its share of the blockbuster hepatitis C market.

Published
18 hours ago
From
Fierce Biotech
France uses tax to put pressure on hepatitis C drug prices

France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

Published
18 hours ago
From
Reuters
UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use.

Published
19 hours ago
From
EATG
PrEP will need high adherence, high effectiveness and high coverage in specific populations to be affordable in the US, New York study finds

A study based on New York City that modelled pre-exposure prophylaxis (PrEP) uptake there has found that in order to be affordable, PrEP would need to be

Published
19 hours ago
By
Gus Cairns
Selling the End of AIDS

As slogans anticipating an end to the AIDS epidemic gain popularity, skeptics worry that such promises are hollow and unrealistically ambitious, and that failure to deliver will ultimately set back efforts to combat HIV.

Published
19 hours ago
From
Poz
Late diagnosis of HIV blamed on Coalition's health reforms

Health experts are reporting disturbing increases in the number of people being diagnosed late with the HIV virus in England. They warn that healthcare reforms, which, they say, have "fragmented" a previously "seamless sexual health service", may be a major reason for the delays, and have called for an investigation.

Published
29 September 2014
From
The Independent
← First12345...445Next →

Filter by country